The PE Ratio as of May 2025 (TTM) for AnGes, Inc. (AMGXF) is -0.46

According to AnGes, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.46. This represents a change of -58.46% compared to the average of -1.11 of the last 4 quarters.

AnGes, Inc. (AMGXF) Historical PE Ratio (quarterly & annually)

How has AMGXF PE Ratio performed in the past?

The mean historical PE Ratio of AnGes, Inc. over the last ten years is -9.03. The current -0.46 PE Ratio has changed 409.62% with respect to the historical average. Over the past ten years (40 quarters), AMGXF's PE Ratio was at its highest in in the September 2023 quarter at 147.82. The PE Ratio was at its lowest in in the June 2020 quarter at -61.54.

AnGes, Inc. (AMGXF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of AnGes, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

AnGes, Inc. (AMGXF) Average PE Ratio

How has AMGXF PE Ratio performed in the past?

The current PE Ratio of AnGes, Inc. (AMGXF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

AnGes, Inc. (AMGXF) PE Ratio vs. Peers

How is AMGXF’s PE Ratio compared to its peers?

AnGes, Inc.’s PE Ratio is greater than Lexicon Pharmaceuticals, Inc. (-1.09), greater than Blueprint Medicines Corporation (-41.53), less than Galera Therapeutics, Inc. (-0.15), greater than Day One Biopharmaceuticals, Inc. (-9.29), less than Halozyme Therapeutics, Inc. (13.21), greater than Checkpoint Therapeutics, Inc. (-4.39), greater than Mustang Bio, Inc. (-2.99), greater than Reviva Pharmaceuticals Holdings, Inc. (-0.91), greater than Fortress Biotech, Inc. (-1.11), greater than Kodiak Sciences Inc. (-1.39), greater than Prime Medicine, Inc. (-1.03), less than Reneo Pharmaceuticals, Inc. (22.18), greater than Ginkgo Bioworks Holdings, Inc. (-0.91), less than Ocean Biomedical, Inc. (-0.01), less than Royalty Pharma plc (13.50), less than CohBar, Inc. (-0.10), less than Enveric Biosciences, Inc. (-0.25), less than Elevation Oncology, Inc. (-0.35), less than Hepion Pharmaceuticals, Inc. (-0.00), greater than Zura Bio Limited (-1.60),

Build a custom stock screener for AnGes, Inc. (AMGXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AnGes, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AnGes, Inc. (AMGXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AnGes, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.